USFDA gives final approval for Lacosamide Injection

Last Updated on December 24, 2023 by The Health Master

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to market Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL) single-dose vials, a company statement announced.

The injection is used to treat partial-onset seizures. It is also used with other medicines to treat primary generalized tonic-clonic seizures.

The statement added that it acts on the central nervous system (CNS) to reduce the number and severity of seizures.

It also said that the drug will be manufactured at the group’s injectable manufacturing facility at Jarod, India.

USFDA gives final approval for Seizure injections

USFDA approves Pneumococcal Vaccine for children

USFDA approves this drug for the treatment for weight management

USFDA approves drug for Alopecia, includes safety warning too

 USFDA gives tentative nod to Alembic Pharma for Dasatinib tablets

USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel

9th edition of IP released containing 3,152 Monographs

PCI to introduce One Nation One Cadre guideline for pharmacy across the country

QR code could curb circulation of fake, spurious and substandard medicines

IPGA Telangana organizes National level Symposium on Medical Device Regulation in India

USFDA gives final approval for Seizure injections

Public Service Commission yet to fill up vacant Drugs Inspector posts

These 4 countries accept Indian Pharmacopoeia (IP) as book of standard

DCGI approves India’s first mRNA vaccine against C-19

Govt in talks with UAE to recognise Indian Pharmacopoeia

Drug Alert: NSQ Drugs Lists

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Govt to Mandate QR Codes on All Anti-Cancer Drugs to Combat Counterfeit Crisis
  October 6, 2024
• Need for Regulatory Reforms to improve contraceptive access and workforce participation
  October 6, 2024
• USFDA approval granted for Lamotrigine Extended-Release Tablets USP
  October 5, 2024
• Nutraceutical Industry seeks separate Regulatory Agency
  October 5, 2024
• Boosting Drug Regulatory Efficiency: DCC recommends for Training and Development
  October 4, 2024
• CDSCO Gains Global Recognition: Milestone for Indian Medical Device Industry
  October 3, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: